Real Estate & Construction » Real Estate | Beijing Centergate Technologies

Beijing Centergate Technologies | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,499
2,948
1,040
1,446
1,710
1,744
Cost of Goods Sold (COGS) incl. D&A
3,071
2,545
639
820
940
873
Gross Income
428
403
401
626
770
871
SG&A Expense
467
353
366
505
654
784
EBIT
51
51
-
140
115
89
Unusual Expense
42
-
-
-
-
39
Non Operating Income/Expense
1
60
202
6
10
75
Interest Expense
76
73
73
82
70
47
Pretax Income
165
40
170
66
67
158
Income Tax
36
26
15
21
23
37
Equity in Affiliates
9
1
-
-
-
-
Consolidated Net Income
211
14
154
45
44
121
Net Income
197
14
152
27
14
93
Net Income After Extraordinaries
197
14
152
27
14
93
Net Income Available to Common
197
14
152
27
14
93
EPS (Basic)
0.29
0.02
0.23
0.04
0.02
0.12
Basic Shares Outstanding
675
675
675
675
747
753
EPS (Diluted)
0.29
0.02
0.23
0.04
0.02
0.12
Diluted Shares Outstanding
675
675
675
675
747
753
EBITDA
13
92
70
192
182
214
Other Operating Expense
11
2
5
19
1
2
Non-Operating Interest Income
1
1
6
1
11
1
Minority Interest Expense
14
-
2
18
29
28

About Beijing Centergate Technologies

View Profile
Address
Shenzhou Building
Beijing Beijing 100081
China
Employees -
Website http://www.centek.com.cn
Updated 07/08/2019
Beijing Centergate Technologies (Holding) Co., Ltd. engages in the development, management and investment of real estate. It operates business through four business segments-biomedical, personal care products, real estate & construction and other business. It mainly engages in the biomedical product preparation including tablets, injections, APIs, capsule, oral solution, granules, narcotic drugs, personal care products, manufacture and sale of commercial concrete and cement products.